Comprehensive Guide on Pharmaceutical-Grade Nickel Acetylacetonate 3264-82-2 Features & Safety
ProcurenetShort description
Discover our Pharmaceutical-Grade Nickel Acetylacetonate 3264-82-2, a highly pure organic synthesis catalyst. Key features include:
- Melting Point: 230u00b0C
- Density: 0.145 g/cm3
- Refractive Index: 1.57-1.64
Soluble in water with a flash point above 200u00b0C, it catalyzes polymerization, oxidation, and more. For safe usage, store below 30u00b0C and use with protective equipment. We provide variable packaging from 1 kg to 25 kg drums or customizable sizes.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Pharmaceutical-Grade Nickel Acetylacetonate 3264-82-2: An In-Depth Look
A comprehensive examination of the pharmaceutical-grade Nickel Acetylacetonate 3264-82-2, its unique features, applications, and safety precautions.
Attributes
- Molecular Formula: C10H14NiO4
- Melting Point: 230°C (dec) (lit.)
- Boiling Point: 220°C at 11 mmHg
- Density: 0.145 g/cm3
- Refractive Index: 1.57-1.64
- Flash Point: > 200°C
- Solubility: Soluble in water
- Sensitivity: Hygroscopic nature
Applications
Nickel Acetylacetonate 3264-82-2 is a powerful chemical reagent, with a vital role in accelerating various organic reactions and syntheses. Its effectiveness as a potent catalyst provides significant value to pharmaceutical and chemical industries.
Safety Guidelines and Storage
- Dangerous Goods Mark: T, Xi, Xn
- Danger Category Code: 49-22-43-40
- Safety Instructions: 53-36/37/39-45-36/37
- Storage Conditions: Maintain temperature below 30°C to preserve effectiveness.
Take note of the hygroscopic properties and ensure proper storage conditions to prevent moisture absorption, which might compromise the reagent's efficacy.
Conclusion
To sum up, Nickel Acetylacetonate 3264-82-2 is an indispensable chemical catalyst that boosts the efficiency and rate of various pharmaceutical-grade organic reactions. Combining reliable performance with stringent safety standards, this reagent is integral to chemical and pharmacological operations.
